510(k) K141575
K141575 is an FDA 510(k) premarket notification submitted by Diadexus, Inc. for the device "PLAC TEST FOR LP-PLA2 ACTIVITY". The FDA issued a decision of Substantially Equivalent on December 15, 2014. The device falls under product code NOE (Test, System, Immunoassay, Lipoprotein-Associated Phospholipase A2), a Class II device regulated under 21 CFR 866.5600. Diadexus, Inc. has at least 6 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- December 15, 2014
- Date Received
- June 12, 2014
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Test, System, Immunoassay, Lipoprotein-Associated Phospholipase A2
- Device Class
- Class II
- Regulation Number
- 866.5600
- Review Panel
- IM
- Submission Type
The Lipoprotein-associated Phospholipase A2, Immunoassay, System, Test, is intended to measure lipoprotein-associated phospholipase A2 in human plasma in conjunction with clinical evaluation and other patient risk factors including biochemical analyses as an aid in predicting risk for coronary heat disease. This device differs from the classification regulation in that it is a different analyte, thus a NEW marker for predicting risk of coronary heart disease. This device is measuring an enzyme that is produced by macrophages where as the regulation is for the measurement of a lipoprotein.